A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Hoffmann-La Roche
National Cancer Institute (NCI)
Weill Medical College of Cornell University
British Columbia Cancer Agency
Fundación de investigación HM
University of Iowa
University of Iowa
University of Iowa
Case Comprehensive Cancer Center
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Medical College of Wisconsin
University of Iowa
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Novartis
National Institutes of Health Clinical Center (CC)
Neotropix